Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Philips, HeartFlow Cut FFR R&D, Commercial Deal

Executive Summary

HeartFlow has signed another deal with one of the medical imaging giants to promote its HeartFlow FFRct Analysis technology for diagnosing coronary heart disease, this time with Dutch group Philips. The collaboration will further expand Philips' intravascular imaging offerings, a space in which it is focused on becoming a leader.


Related Content

Market Intel: Increasingly Less-Invasive Diagnostic Techs To Disrupt Interventional Cardio Market
Spectranetics Gives Philips Adjacent Territory In Image-Guided Therapy
Philips Grows Image-Guided Intervention Focus With Spectranetics Buy
£9m NHS Savings With HeartFlow 'Virtual FFR' Gets NICE Nod


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts